Form 8-K, current report

Estrella Immunopharma, Inc., 8-K filed 2026-09-08

Published 8 Sep 2026 · retrieved 9 Sep 2026, 02:30 EDT · version 1Official source

The full text was pulled automatically from the official source and is not Threadline News reporting; the annotations alongside it are.

Filing record

¶1

8-K filed with the Securities and Exchange Commission by Estrella Immunopharma, Inc. (CIK 0001844417) on 2026-09-08.

¶2

Accession number 0001213900-26-098123. EDGAR reports the filing package as 242 KB. The filing index, including every exhibit, is at https://www.sec.gov/Archives/edgar/data/1844417/000121390026098123/0001213900-26-098123-index.htm.

Items reported on the cover

¶1

Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing